Grifols, S.A. (GRFS) Financials

GRFS Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 23.0 billion 14.0 billion
Dec. 31, 2025 23.2 billion 14.2 billion
Sept. 30, 2025 23.4 billion 14.5 billion
June 30, 2025 23.3 billion 14.3 billion

GRFS Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 67.6 million ?
Dec. 31, 2025 393.5 million ?
Sept. 30, 2025 299.7 million ?
June 30, 2025 112.0 million ?

GRFS Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 85.0 million
Dec. 31, 2025 114.3 million
Sept. 30, 2025 149.0 million
June 30, 2025 138.0 million

GRFS Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 805.3 million 10.4 billion -
Dec. 31, 2025 968.1 million 8.7 billion 1.1 billion
Sept. 30, 2025 968.7 million 10.7 billion -
June 30, 2025 666.9 million 8.8 billion 1.3 billion

GRFS Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 779.9 million
Dec. 31, 2025 799.0 million
Sept. 30, 2025 798.6 million
June 30, 2025 811.6 million

GRFS Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 60.6 million 104.8 million 327.3 million -
Dec. 31, 2025 97.9 million 159.0 million 320.2 million -
Sept. 30, 2025 82.2 million 113.9 million 321.3 million -
June 30, 2025 71.0 million 113.4 million 333.3 million -

GRFS Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.0 billion 1.3 billion
Dec. 31, 2025 2.3 billion 1.5 billion
Sept. 30, 2025 2.2 billion 1.3 billion
June 30, 2025 2.2 billion 1.4 billion

GRFS

Price: $7.47

52 week price:
7.39
11.14

Dividend Yield: 2.41%

Payout Ratio Range:
0.00%
182.18%

Dividend Per Share: 0.18 USD

Earnings Per Share: 0.70 USD

P/E Ratio: 11.14

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Spain

Volume: 924384

Ebitda: 362.6 million

Market Capitalization: 6.3 billion

Links: